NXTC - NextCure, Inc.
12.39
-0.370 -2.986%
Share volume: 80,651
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$12.76
-0.37
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 03-06-2025 | 05-01-2025 | 08-07-2025 | 11-05-2025 | 03-05-2026 | |
| Cash flow financing | 1.000 K | 106.000 K | 1.000 K | 36.000 K | 0.000 | 2.019 M | 0.000 | 20.293 M | |
| Other financing cash flows | 1.000 K | 21.000 K | 1.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 5.276 M | 2.490 M | 6.854 M | 25.000 K | -5.900 M | -16.935 M | 0.000 | 18.658 M | |
| Net income | -17.107 M | -15.404 M | -11.540 M | -11.603 M | -10.976 M | -26.808 M | -8.624 M | -9.436 M | |
| Depreciation | 790.000 K | 701.000 K | 700.000 K | 674.000 K | 654.000 K | 633.000 K | 533.000 K | 365.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 17.881 M | 12.160 M | 18.307 M | 6.958 M | 7.094 M | 3.759 M | 8.700 M | 6.003 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 37.000 K | 301.000 K | 170.000 K | -34.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 5.276 M | 2.490 M | 6.854 M | 25.000 K | -5.900 M | -16.935 M | 2.432 M | 18.658 M |